Monogram terminates Mount Sinai license; pays $4M with cash and Series E Preferred

Monogram Technologies Inc.

• Terminated exclusive license with Icahn School of Medicine at Mount Sinai, effective July 10, 2025.
• Pays $4M total: $500k cash and 35,000 shares of new Series E Preferred Stock ($3.5M liquidation preference).
• Series E Preferred is perpetual, $100/sh liquidation preference, no voting rights, 10% cumulative dividend, convertible after July 1, 2026.
• Mandatory redemption of Series E upon securities offerings ≥$25M gross proceeds or change of control ≥40% voting power.
• Mutual release of claims; no further payments due under original license agreement.